Histoplasmosis in children; hiv/aids not a major driver

Abstract

The classification of histoplasmosis as an AIDS‐defining illness has largely attributed its occurrence in people to the presence of HIV/AIDS especially in Africa. Prior to the advent of the HIV/AIDS epidemic, several cases of histoplasmosis were documented both in the pediatric and adult populations. Our review revealed 1461 reported cases of pediatric histoplasmosis globally in the last eight decades (1939–2021). North America (n = 1231) had the highest number of cases, fol-lowed by South America (n = 135), Africa (n = 65), Asia (n = 26) and Europe (n = 4). Histoplasmosis was much more common in the non‐HIV pediatric population (n = 1418, 97.1%) compared to the HIV population. The non‐HIV factors implicated were, childhood malignancies (n = 207), such as leukemias and lymphomas as well as their treatment, lung diseases (n = 7), environmental exposures and toxins (n = 224), autoimmune diseases (n = 12), organ transplants (n = 12), long‐term steroid therapy (n = 3), the use of immunosuppressive drugs such as TNF‐alpha inhibitors (n = 7) malnutri-tion (n = 12), histiocytosis (n = 3), Hyper immunoglobulin M and E syndromes (n = 15, 1.2%), pan-cytopenia (n = 26), diabetes mellitus (n = 1) and T‐cell deficiency (n = 21). Paediatricians should always consider or rule out a diagnosis of histoplasmosis in children presenting with symptoms suggestive of the above clinical conditions.